FEB 21, 2016 06:00 AM PST

Mysterious lipids increase as cancer cells die

The role of organic compounds called “sphingolipids” in cancer remains a mystery—in particular, the way in which cancer cells die.

A new study sheds light on this topic, tracing how levels of various sphingolipids spike inside cancer cells when the cells are undergoing a highly organized form of cellular death called apoptosis.
 
Above, the colon cancer cells in red are unharmed. The ones in green are undergoing a highly orchestrated form of cellular death called

In normal cells, apoptosis—akin to cellular suicide—happens when a cell is damaged. The self-destruction is healthy: It’s thought to help the body rid itself of dysfunctional cells.

Cancer cells are adept at evading apoptosis, which is one reason they multiply out of control. But in the new study, the scientists forced the cells to commit suicide, then carefully tracked what happened inside the cells as they self-destructed.

“A better understanding of the machinery of apoptosis, at the fundamental level, can perhaps help us find new therapeutics for cancer,” says G. Ekin Atilla-Gokcumen, the study’s senior author and an assistant professor of chemistry at the University at Buffalo.

Previous studies have established that sphingolipid levels rise during apoptosis in cancer cells, but the new research — which appears in the journal Chemistry & Biology — makes two important contributions.

First, the scientists found that the sphingolipid spikes may be unique to cancer. The team observed the phenomenon in three types of cancer cells (colon, ovarian, and breast) during apoptosis, but not in two types of noncancerous cells (colon fibroblast cells, and retinal epithelial cells) undergoing the same process, Atilla-Gokcumen says.

Second, the scientists were able to create a detailed portrait of how the levels of many different sphingolipid compounds changed over time as death unfolded.

“We show that dying cancer cells appear to carefully tune the levels of individual sphingolipids as apoptosis progresses,” Atilla-Gokcumen says. “Different compounds accumulate at different rates. Our results build on evidence that numerous sphingolipids are involved in managing this process of cellular death.”

The study used a powerful technique called untargeted lipodomics to analyze the entire lipodome—the collection of all lipids within cells. Lipids, which include compounds like fats and waxes, are one of the major classes of molecules found in the body, and there are thousands of them.

Despite this huge diversity, the study found that sphingolipids accounted for nearly 90 percent of lipids that accumulated in colon cancer cells during apoptosis.

The findings emphasize what previous studies have found: that sphingolipids, which have been linked to some of the body’s most mysterious processes, such as cell proliferation and differentiation, appear to be highly active during cellular suicide.

The research also raises new questions, including what accounts for the differences in sphingolipid changes inside cancerous and noncancerous cells. The team found that noncancerous colon cells already had high levels of sphingolipids prior to apoptosis, whereas colon cancer cells had lower levels. This could help explain why sphingolipids spiked in the cancer cells during apoptosis but not in noncancerous cells, but more research must be done before scientists can understand the implications of this finding.

Source: University at Buffalo

This article was originally posted on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
JUL 23, 2018
Cancer
JUL 23, 2018
Increased Vitamin D Is Not Cancer Preventative
A new study in July's JAMA Oncology outlines the results of a 4-year study in New Zealand focused on vitamin D and if it is positively associated with cancer prevention....
JUL 30, 2018
Cancer
JUL 30, 2018
Key Markers in Melanoma Disease Progression
Researchers have found key markers in identifying the progression of melanoma by stages....
AUG 07, 2018
Cancer
AUG 07, 2018
Renal Cell Carcinoma and Myelodysplastic Syndrome Show Epigenetic Association
DNA methylation patterns in renal cell carcinoma (RCC) have a strong association with myelodysplastic syndrome DNA hypermethylation later in life....
SEP 11, 2018
Cannabis Sciences
SEP 11, 2018
New Evidence Shows Marijuana Smoke is Not the Same as Cigarette Smoke, at Least, in Terms of Lung Disease.
A recent report published in the journal Breathe by scientists in the UK suggests that chronic marijuana smoking may not cause the same deleterious effects...
OCT 17, 2018
Cell & Molecular Biology
OCT 17, 2018
Saving Patients From Unnecessary Chemotherapy with a Blood Test
Often, cancer patients get chemotherapy after surgery to ensure that their cancer will not come back; for many it's not needed....
OCT 21, 2018
Technology
OCT 21, 2018
New Technology Detects Early-Stage Lung Cancer
According to recent research published in the Journal of Molecular Diagnostics, outcomes of patients with non-small-cell lung carcinoma (NSCLC) may be impr...
Loading Comments...